Hélène Blasco

5PUBLICATIONS
7CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersCentral nervous systemGene mappingMetabolic medicine
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Aug 04, 2025
scFv intrabody targeting wildtype TDP-43 presents protective effects in a cellular model of TDP-43 proteinopathy.

Yara Al Ojaimi, Rudolf Hergesheimer, Anna A Chami

|Jun 29, 2025
Identification of disease-associated molecular signatures in the Prp-TDP-43A315T mouse model of ALS: Toward preclinical biomarker development.

Yara Al Ojaimi, Samira Osman, Hugo Alarcan

|Jun 09, 2021
TDP43 aggregates: the 'Schrödinger's cat' in amyotrophic lateral sclerosis.

Débora Lanznaster, Rudolf Hergesheimer, Patrick Vourc'h

|Jan 07, 2021
Effect of familial clustering in the genetic screening of 235 French ALS families.

Philippe Corcia, William Camu, Celine Brulard

|Jun 06, 2018
A pharmaco-metabolomics approach in a clinical trial of ALS: Identification of predictive markers of progression.

Hélène Blasco, Franck Patin, Amandine Descat

Pageof 1

Frequent Collaborators

2 joint publications

Débora Lanznaster

1 joint publications

Philippe Corcia

1 joint publications

Jean-Philippe Camdessanché

1 joint publications

Yara Al Ojaimi